What is the current trend for ‘anticancer’ clinical pipelines?

Published: 2016-02-12 15:45:10

Updated: 2016-02-12 15:45:10

Approaches for R&Ds, including Open Innovation, have never been more diversified over new drug candidates. Domestic pharmaceutical companies are also racing to strengthen their new drug pipelines to follow the trend.

Actively using the Open Innovation strategy to fill up relatively decreased pipelines compared to a number of technology transfers, Hanmi Pharm announced to focus on 4 types of tr...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.